Preconditioning by Cilostazol protects against cold hepatic ischemia-reperfusion injury

Annals of Transplantation

Volumn 20, Issue , 2015, Pages 160-168

  von Heesen, Maximilian ^a   Müller, Simon ^a   Keppler, Ulrich ^a,b   Strowitzki, Moritz J ^a,b   Scheuer, Claudia ^a   Schilling, Martin K ^a,c   Menger, Michael D ^a   Moussavian, Mohammed R ^a,d  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Herz Zentrum Hirslanden Zentralschweiz   (Switzerland)

^d ST BONIFATIUS HOSPITAL   (Germany)

Author keywords

Cyclic AMP; Microcirculation; Organ preservation; Reperfusion injury

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CASPASE 3; CILOSTAZOL; INTERCELLULAR ADHESION MOLECULE 1; LACTATE DEHYDROGENASE; PHOSPHODIESTERASE III INHIBITOR; TETRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILE FLOW; CELL DEATH; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; EXPLANT; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; ISCHEMIC PRECONDITIONING; LIVER FUNCTION; LIVER ISCHEMIA; LIVER TRANSPLANTATION; NONHUMAN; POTASSIUM TRANSPORT; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; REPERFUSION INJURY; WESTERN BLOTTING; ANIMAL; APOPTOSIS; DRUG EFFECTS; ENDOTHELIUM CELL; FEMALE; LIVER; MALE; METABOLISM; PATHOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; APOPTOSIS; ENDOTHELIAL CELLS; FEMALE; INTERCELLULAR ADHESION MOLECULE-1; ISCHEMIC PRECONDITIONING; LIVER; MALE; PHOSPHODIESTERASE 3 INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TETRAZOLES;

EID: 84928009259     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: 10.12659/AOT.893031     Document Type: Article

References (44)

1. Azevedo LD, Stucchi RS, Ataíde EC, Boin IF: Assessment of causes of early death after twenty years of liver transplantation. Transplant Proc, 2013; 45: 1116-18
2. Schemmer P, Mehrabi A, Kraus T et al: New aspects on reperfusion injury to liver-impact of organ harvest. Nephrol Dial Transplant, 2004; 19(Suppl.4): 26-35
3. Silva MA, Mirza DF, Murphy N et al: Intrahepatic complement activation, sinusoidal endothelial injury, and lactic acidosis are associated with initial poor function of the liver after transplantation. Transplantation, 2008; 85: 718-25
4. Vollmar B, Menger MD: The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair. Physiol Rev, 2009; 89: 1269-339
5. Kotsch K, Ulrich F, Reutzel-Selke A et al: Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: a prospective randomized controlled trial. Ann Surg, 2008; 248: 1042-50
6. Moussavian MR, Scheuer C, Schmidt M et al: Multidrug donor preconditioning prevents cold liver preservation and reperfusion injury. Langenbecks Arch Surg, 2011; 396: 231-41
7. Lee LY, Kaizu T, Toyokawa H et al: Carbon monoxide induces hypothermia tolerance in Kupffer cells and attenuates liver ischemia/reperfusion injury in rats. Liver Transpl, 2011; 17: 1457-66
8. Gracia-Sancho J, García-Calderó H, Hide D et al: Simvastatin maintains function and viability of steatotic rat livers procured for transplantation. J Hepatol, 2013; 58: 1140-46
9. Arai M, Peng XX, Currin RT et al: Protection of sinusoidal endothelial cells against storage/reperfusion injury by prostaglandin E2 derived from Kupffer cells. Transplantation, 1999; 68: 440-45
10. Schemmer P, Bradford BU, Rose ML et al: Intravenous glycine improves survival in rat liver transplantation. Am J Physiol, 1999; 276: G924-32
11. Schmeding M, Hunold G, Ariyakhagorn V et al: Erythropoietin reduces ischemia-reperfusion injury after liver transplantation in rats. Transpl Int, 2009; 22: 738-46
12. von Heesen M, Seibert K, Hülser M et al: Multidrug donor preconditioning protects steatotic liver grafts against ischemia-reperfusion injury. Am J Surg, 2012; 203: 168-76
13. De Rougemont O, Lehmann K, Clavien PA: Preconditioning, organ preservation, and postconditioning to prevent ischemia-reperfusion injury to the liver. Liver Transpl, 2009; 15: 1172-82
14. Selzner N, Rudiger H, Graf R, Clavien PA: Protective strategies against ischemic injury of the liver. Gastroenterology, 2003; 125: 917-36
15. Kobayashi T, Sugawara Y, Ohkubo T et al: Effects of amrinone on hepatic ischemia-reperfusion injury in rats. J Hepatolm 2002; 37: 31-38
16. Kume M, Banafsche R, Yamamoto Y et al: Dynamic changes of post-ischemic hepatic microcirculation improved by a pre-treatment of phosphodiesterase-3 inhibitor, milrinone. J Surg Res, 2006; 136: 209-18
17. Ito H, Miyakoda G, Mori T: Cilostazol inhibits platelet-leukocyte interaction by suppression of platelet activation. Platelets, 2004; 15: 293-301
18. Mori D, Ishii H, Kojima C et al: Cilostazol inhibits monocytic cell adhesion to vascular endothelium via upregulation of cAMP. J Atheroscler Thromb, 2007; 14: 213-18
19. Shimizu E, Kobayashi Y, Oki Y et al: OPC-13013, a cyclic nucleotide phosphodiesterase type III, inhibitor, inhibits cell proliferation and transdifferentiation of cultured rat hepatic stellate cells. Life Sci, 1999; 64: 2081-88
20. Kohda N, Tani T, Nakayama S et al: Effect of Cilostazol, a phosphodiesterase III inhibitor, on experimental thrombosis in the porcine carotid artery. Thromb Res, 1999; 96: 261-68
21. Iba T, Kidokoro A, Fukunaga M et al: Comparison of the protective effects of type III phosphodiesterase (PDE3) inhibitor (Cilostazol) and acetylsalicylic acid on intestinal microcirculation after ischemia reperfusion injury in mice. Shock, 2006; 26: 522-26
22. Mizutani A, Murakami K, Okajima K et al: Olprinone reduces ischemia/reperfusion-induced acute renal injury in rats through enhancement of cAMP. Shock, 2005; 24: 281-87
23. Ikegami T, Nishizaki T, Hiroshige S et al: Experimental study of a type 3 phosphodiesterase inhibitor on liver graft function. Br J Surg, 2001; 88: 59-64
24. Orii R, Sugawara Y, Hayashida M et al: Effects of amrinone on ischaemiareperfusion injury in cirrhotic patients undergoing hepatectomy: a comparative study with prostaglandin E1. Br J Anaesth, 2000; 85: 389-95
25. Yamaguchi K, Kawahara T, Kumakura S et al: Effect of olprinone, a phosphodiesterase III inhibitor, on hepatic ischemia-reperfusion injury in rats. Shock, 2010; 33: 436-41
26. Kucuk C, Akcan A, Akyýldýz H et al: Effects of amrinone in an experimental model of hepatic ischemia-reperfusion injury. J Surg Res, 2009; 151: 74-79
27. von Heesen M, Hülser M, Seibert K et al: Split-liver procedure and inflammatory response: improvement by pharmacological preconditioning. J Surg Res, 2011; 168: 125-35
28. Omi H, Okayama N, Shimizu M et al: Cilostazol inhibits high glucose-mediated endothelial-neutrophil adhesion by decreasing adhesion molecule expression via NO production. Microvasc Res, 2004; 68: 119-25
29. Craciun EM, Altfelder F, Kuss N et al: Anti-inflammatory effects of selected drugs on activated neonatal and adult neutrophils. Scand J Clin Lab Invest, 2013; 73: 407-13
30. Igawa T, Tani T, Chijiwa T et al: Potentiation of anti-platelet aggregating activity of cilostazol with vascular endothelial cells. Thromb Res, 1990; 57: 617-23
31. Kim CW, Yun JW, Bae IH et al: Evaluation of anti-platelet and anti-thrombotic effects of cilostazol with PFA-100® and Multiplate® whole blood aggregometer in vitro, ex vivo and FeCl3-induced thrombosis models in vivo. Thromb Res, 2011; 127: 565-70
32. Menger MD, Vollmar B: Adhesion molecules as determinants of disease: from molecular biology to surgical research. Br J Surg, 1996; 83: 588-601
33. Vollmar B, Glasz J, Menger MD, Messmer K: Leukocytes contribute to hepatic ischemia/reperfusion injury via intercellular adhesion molecule-1-mediated venular adherence. Surgery, 1995; 117: 195-200
34. Vollmar B, Glasz J, Leiderer R et al: Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion. Am J Pathol, 1994; 145: 1421-31
35. Lee SW, Song YS, Shin SH et al: Cilostazol protects rat chondrocytes against nitric oxide-induced apoptosis in vitro and prevents cartilage destruction in a rat model of osteoarthritis. Arthritis Rheum, 2008; 58: 790-800
36. Esposito E, Mazzon E, Paterniti I et al: Olprinone attenuates the acute inflammatory response and apoptosis after spinal cord trauma in mice. PLoS One, 2010; 5: e12170
37. Nishiki T, Kitada H, Okabe Y et al: Effect of milrinone on ischemia-reperfusion injury in the rat kidney. Transplant Proc, 2011; 43: 1489-94
38. Kim JS, He L, Qian T, Lemasters JJ: Role of the mitochondrial permeability transition in apoptotic and necrotic death after ischemia/reperfusion injury to hepatocytes. Curr Mol Med, 2003; 3: 527-35
39. Lemasters JJ, Qian T, He L et al: Role of mitochondrial inner membrane permeabilization in necrotic cell death, apoptosis, and autophagy. Antioxid Redox Signal, 2002; 4: 769-81
40. Gujral JS, Bucci TJ, Farhood A, Jaeschke H: Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: apoptosis or necrosis? Hepatology, 2001; 33: 397-405
41. El-Gibaly AM, Scheuer C, Menger MD, Vollmar B: Improvement of rat liver graft quality by pifithrin-alpha-mediated inhibition of hepatocyte necrapoptosis. Hepatology, 2004; 39: 1553-62
42. Weidenbach H, Beckh K, Schricker T et al: Enhancement of hepatic glucose release and bile flow by the phosphodiesterase-III-inhibitor enoximone in the perfused rat liver. Life Sci, 1995; 56: 1721-26
43. Scholz H: Phosphodiesterase inhibition as a therapeutic principle. Z Kardiol, 1994; 83(Suppl.2): 1-5
44. Kato A, Gores GJ, LaRusso NF: Secretin stimulates exocytosis in isolated bile duct epithelial cells by a cyclic AMP-mediated mechanism. J Biol Chem, 1992; 267: 15523-29